tiprankstipranks
Blurbs

Maxim Group Keeps Their Buy Rating on NexGel Inc (NXGL)

In a report released yesterday, Naz Rahman from Maxim Group maintained a Buy rating on NexGel Inc (NXGLResearch Report), with a price target of $5.00. The company’s shares opened today at $1.32.

According to TipRanks, Rahman is an analyst with an average return of -38.3% and a 16.88% success rate. Rahman covers the Healthcare sector, focusing on stocks such as Agile Therapeutics, 9 Meters Biopharma, and Clene.

Currently, the analyst consensus on NexGel Inc is a Moderate Buy with an average price target of $5.00.

See Insiders’ Hot Stocks on TipRanks >>

NXGL market cap is currently $11.26M and has a P/E ratio of -1.31.

Based on the recent corporate insider activity of 15 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of NXGL in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

NexGel Inc is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics.

Read More on NXGL:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles